Organ Transplantation Software and Services Market

Global Organ Transplantation Software and Services Market Size, Trends & Analysis - Forecasts to 2027 By Component (Digital Transplant Software/Solutions and Transplant Services), By Application (Transplant Process Administration, Patient Management Software, and Organ Donor Management), By Transplant Type (Heart, Kidney, Liver, Lungs, Pancreas, and Tissue), By End-User (Hospitals, Blood Bank, Stem cell Bank, and Organ Bank), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa), Competitive Landscape Company Market Share Analysis, and Competitor Analysis

Category Healthcare

Format

This report was recently updated on November 16 2024 with the latest and most recent market numbers

Organ Transplantation Software and Services Market Size

The global organ transplantation software and services market is projected to grow at a CAGR value of 11.5% from 2022 to 2027. The organ transplantation software and services market is largely driven by the growing instances of chronic illnesses and organ failures stemming from injuries and illness. The growing demand for organ transplants has increased the adoption of software services to monitor donor availability, health, and other data to ensure smooth transplant procedures. The growing adoption of cloud-based services is expected to further enhance the functionalities of transplantation software. The greater functionalities, ease of access, and remote access features of cloud-based software are expected to result in an uptick in demand for transplantation software and services during the forecast period.

As per the United Network for Organ Sharing (UNOS) data, the number of transplant procedures has been rising in the United States. From 39,719 donor transplants in 2019 and 39,036 transplants in 2020, the number of transplants has increased to 41,354 in 2021. Growing incidence of organ failures arising from complications during surgery, inflammation, accident, infection, increased metabolic rate, metabolic activity, and respiratory distress, among others are the major cause for the growing number of transplants.

The increased awareness among the public on the importance of organ has increased the number of organ donors across the globe. With a single organ donor capable of saving up to eight lives, more and more people are becoming organ donors increasing the demand for transplantation software and services. These softwares are capable of providing real-time access to transplant-specific data to help caregivers to track their transplant effectiveness, quality, and easily follow trends to ensure smooth workflow. With improved data collection, cleaning, and analytics, transplantation software allows hospitals and clinics to manage transplant data for small single-organ, and large multi-organ programs. They also allow healthcare providers to ensure regulatory compliance and meet their quality assurance goals and track transplant-specific information throughout all phases of solid organ transplant, including adverse events.

The market’s growth is restrained by the low number of transplants, the high cost of software and services, and the lack of adequate donors to meet the high demand. Furthermore, the stringent requirements and challenges surrounding successful transplants are also restraining the growth of the market.

The COVID-19 pandemic has caused various issues surrounding organ transplants. Over expenditure of healthcare resources from a large number of COVID cases increased scrutiny on hospital practices to prevent the spread of the virus, and delays in surgeries have restrained the market. While the pandemic has increased the demand for transplants, the market for transplantation software and services has taken a hit and is expected to bounce back during the forecast period.

The transplantation software and services market is largely driven by the growing adoption of cloud-based technologies, increased demand for transplant services, need for donor and recipient tracking, and post-transplant observation.

global organ transplantation software and services market

Organ Transplantation Software and Services Market: By Component

Based on the components, the organ transplantation software and services market is segmented into digital transplant software/solutions and transplant services. The transplant software/solutions segment is expected to hold the largest piece of the market during the forecast period. Growing demand for organ transplants software for monitoring patient data, tracking quality, patient, donor, and other transplant data, and the need for real-time data analytics in the industry have led to the dominance of the digital transplant software/solutions segment.

Organ Transplantation Software and Services Market: By Application

Based on the various avenues of application of organ transplantation software and services, the market is segmented into transplant process administration, patient management software, and organ donor management. The organ donor management segment held the lion’s share of the market. The growing number of organ donors and the need to monitor their health and to prevent severe autonomic and inflammatory responses after brain death are increasing the demand for organ donor management.

Organ Transplantation Software and Services Market: By Transplant Type

Based on the various transplant types, the market is segmented into heart, kidney, liver, lungs, pancreas, and tissue. The kidney segment held the lion’s share of the market. The growing demand incidence of kidney failures from chronic diseases and the growing number of kidney donors have led to the dominance of this segment.

Organ Transplantation Software and Services Market: By End-User

Based on the various end-users, the market is segmented into hospitals, blood bank, stem cell bank, and organ bank. The organ bank segment held the lion’s share of the market. The demand for organs and the large amounts of data being generated through donor and recipient health monitoring have increased the demand for organ transplantation software and solutions in organ banks.

asia pacific organ transplantation software and services market

Organ Transplantation Software and Services Market: By Region

Based on region, the market can be segmented into various regions such as North America, Europe, Central and South America, Middle East and North Africa, and Asia Pacific regions. The North American region is expected to be the dominant force in the market during the forecast period. Heavy expenditure on healthcare services, a growing number of donors, an increasing incidence of chronic diseases, organ failures, and a large geriatric population in the region have contributed to the dominance of the region’s market.

The APAC region is expected to become the fastest-growing market during the forecast period. The growing number of organ donors, increasing demand for organ transplants, and increasing expenditure on healthcare in the region are expected to be the major drivers of the market in the APAC region.

Organ Transplantation Software and Services Market Share and Competitor Analysis

Aithent Inc., CareDx, Infor-Med Inc., Transplant Connect, Talend, Inova, Afflo, TatvaSoft, Optum, Inc., LifeCell Corporation, Mid-America Transplant Services, Australian Red Cross Blood Service, Acelity L.P. Inc., CryoLife, Inc., Exactech Inc., Folio Biosciences, Dr. Franz Kohler Chemie GmbH, HealthSmart, DaVita, and Labcorp Transplant Services, among others, are the key players in the organ transplantation software and services market.

Please note: This is not an exhaustive list of companies profiled in the report.

Chapter 1 Methodology

1.1 Market Scope & Definitions

1.2 Estimates & Forecast Calculation

1.3 Historical Data Overview and Validation

1.4 Data Sources

1.4.1 Secondary

1.4.2 Primary

Chapter 2 Report Outlook

2.1 Organ Transplantation Software and Services Industry Overview, 2020-2026

2.1.1 Industry Overview

2.1.2 Component Overview

2.1.3 Application Overview

2.1.4 End-User Overview

2.1.5 Transplant Type Overview

2.1.6 Regional Overview

Chapter 3 Organ Transplantation Software and Services Market Trends

3.1 Market Segmentation

3.2 Industry Background, 2020-2026

3.3 Market Key Trends

3.3.1 Positive Trends

3.3.1.1 Advancements in the cloud-based software

3.3.1.2 Growing geriatric population in APAC region

3.3.2 Industry Challenges

3.3.2.1 High cost of organ transplants na dlack of adequate donors

3.4 Prospective Growth Scenario

3.4.1 Component Growth Scenario

3.4.2 Application Growth Scenario

3.4.3 End-User Growth Scenario

3.4.4 Transplant Type Growth Scenario

3.5 COVID-19 Influence over Industry Growth

3.6 Porter’s Analysis

3.7 PESTEL Analysis

3.8 Value Chain & Supply Chain Analysis

3.9 Regulatory Framework

3.9.1 North America

3.9.2 Europe

3.9.3 APAC

3.9.4 LATAM

3.9.5 MEA

3.10 Transplant Type Overview

3.11 Market Share Analysis, 2020

3.11.1 Company Positioning Overview, 2020

Chapter 4 Organ Transplantation Software and Services Market, By Component

4.1 Component Outlook

4.2 Digital Transplant Software/Solutions

4.2.1 Market Size, By Region, 2020-2026 (USD Million)

4.3 Transplant Services

4.3.1 Market Size, By Region, 2020-2026 (USD Million)

Chapter 5 Organ Transplantation Software and Services Market, By End-User

5.1 End-User Outlook

5.2 Hospitals

5.2.1 Market Size, By Region, 2020-2026 (USD Million)

5.3 Blood Bank

5.3.1 Market Size, By Region, 2020-2026 (USD Million)

5.4 Stem cell Bank

5.4.1 Market Size, By Region, 2020-2026 (USD Million)

5.5 Organ Bank

5.5.1 Market Size, By Region, 2020-2026 (USD Million)

Chapter 6 Organ Transplantation Software and Services Market, By Application

6.1 Transplant Process Administration

6.1.1 Market Size, By Region, 2020-2026 (USD Million)

6.2 Patient Management Software

6.2.1 Market Size, By Region, 2020-2026 (USD Million)

6.3 Organ Donor Management

6.3.1 Market Size, By Region, 2020-2026 (USD Million)

Chapter 7 Organ Transplantation Software and Services Market, By Transplant Type

7.1 Heart

7.1.1 Market Size, By Region, 2020-2026 (USD Million)

7.2 Kidney

7.2.1 Market Size, By Region, 2020-2026 (USD Million)

7.3 Liver

7.3.1 Market Size, By Region, 2020-2026 (USD Million)

7.4 Lungs

7.4.1 Market Size, By Region, 2020-2026 (USD Million)

7.5 Pancreas

7.5.1 Market Size, By Region, 2020-2026 (USD Million)

7.6 Tissue

7.6.1 Market Size, By Region, 2020-2026 (USD Million)

Chapter 8 Organ Transplantation Software and Services Market, By Region

8.1 Regional outlook

8.2 North America

8.2.1 Market Size, By Country 2020-2026 (USD Million)

8.2.2 Market Size, By Component, 2020-2026 (USD Million)

8.2.3 Market Size, By Application, 2020-2026 (USD Million)

8.2.4 Market Size, By End-User, 2020-2026 (USD Million)

8.2.5 Market Size, By Transplant Type, 2020-2026 (USD Million)

8.2.6 U.S.

8.2.6.1 Market Size, By Component, 2020-2026 (USD Million)

8.2.4.2 Market Size, By Application, 2020-2026 (USD Million)

8.2.4.3 Market Size, By End-User, 2020-2026 (USD Million)

Market Size, By Transplant Type, 2020-2026 (USD Million)

8.2.7 Canada

8.2.7.1 Market Size, By Component, 2020-2026 (USD Million)

8.2.7.2 Market Size, By Application, 2020-2026 (USD Million)

8.2.7.3 Market Size, By End-User, 2020-2026 (USD Million)

8.2.7.4 Market Size, By Transplant Type, 2020-2026 (USD Million)

8.3 Europe

8.3.1 Market Size, By Country 2020-2026 (USD Million)

8.3.2 Market Size, By Component, 2020-2026 (USD Million)

8.3.3 Market Size, By Application, 2020-2026 (USD Million)

8.3.4 Market Size, By End-User, 2020-2026 (USD Million)

8.3.5 Market Size, By Transplant Type, 2020-2026 (USD Million)

8.3.6 Germany

8.3.6.1 Market Size, By Component, 2020-2026 (USD Million)

8.3.6.2 Market Size, By Application, 2020-2026 (USD Million)

8.3.6.3 Market Size, By End-User, 2020-2026 (USD Million)

8.3.6.4 Market Size, By Transplant Type, 2020-2026 (USD Million)

8.3.7 UK

8.3.7.1 Market Size, By Component, 2020-2026 (USD Million)

8.3.7.2 Market Size, By Application, 2020-2026 (USD Million)

8.3.7.3 Market Size, By End-User, 2020-2026 (USD Million)

8.3.7.4 Market Size, By Transplant Type, 2020-2026 (USD Million)

8.3.8 France

8.3.8.1 Market Size, By Component, 2020-2026 (USD Million)

8.3.8.2 Market Size, By Application, 2020-2026 (USD Million)

8.3.8.3 Market Size, By End-User, 2020-2026 (USD Million)

8.3.8.4 Market Size, By Transplant Type, 2020-2026 (USD Million)

8.3.9 Italy

8.3.9.1 Market Size, By Component, 2020-2026 (USD Million)

8.3.9.2 Market Size, By Application, 2020-2026 (USD Million)

8.3.9.3 Market Size, By End-User, 2020-2026 (USD Million)

8.3.9.4 Market Size, By Transplant Type, 2020-2026 (USD Million)

8.3.10 Spain

8.3.10.1 Market Size, By Component, 2020-2026 (USD Million)

8.3.10.2 Market Size, By Application, 2020-2026 (USD Million)

8.3.10.3 Market Size, By End-User, 2020-2026 (USD Million)

8.3.10.4 Market Size, By Transplant Type, 2020-2026 (USD Million)

8.3.11 Russia

8.3.11.1 Market Size, By Component, 2020-2026 (USD Million)

8.3.11.2 Market Size, By Application, 2020-2026 (USD Million)

8.3.11.3 Market Size, By End-User, 2020-2026 (USD Million)

8.3.11.4 Market Size, By Transplant Type, 2020-2026 (USD Million)

8.4 Asia Pacific

8.4.1 Market Size, By Country 2020-2026 (USD Million)

8.4.2 Market Size, By Component, 2020-2026 (USD Million)

8.4.3 Market Size, By Application, 2020-2026 (USD Million)

8.4.4 Market Size, By End-User, 2020-2026 (USD Million)

8.4.5 Market Size, By Transplant Type, 2020-2026 (USD Million)

8.4.6 China

8.4.6.1 Market Size, By Component, 2020-2026 (USD Million)

8.4.6.2 Market Size, By Application, 2020-2026 (USD Million)

8.4.6.3 Market Size, By End-User, 2020-2026 (USD Million)

8.4.6.4 Market Size, By Transplant Type, 2020-2026 (USD Million)

8.4.7 India

8.4.7.1 Market Size, By Component, 2020-2026 (USD Million)

8.4.7.2 Market Size, By Application, 2020-2026 (USD Million)

8.4.7.3 Market Size, By End-User, 2020-2026 (USD Million)

8.4.7.4 Market Size, By Transplant Type, 2020-2026 (USD Million)

8.4.8 Japan

8.4.8.1 Market Size, By Component, 2020-2026 (USD Million)

8.4.8.2 Market Size, By Application, 2020-2026 (USD Million)

8.4.8.3 Market Size, By End-User, 2020-2026 (USD Million)

8.4.8.4 Market Size, By Transplant Type, 2020-2026 (USD Million)

8.4.9 Australia

8.4.9.1 Market Size, By Component, 2020-2026 (USD Million)

8.4.9.2 Market size, By Application, 2020-2026 (USD Million)

8.4.9.3 Market Size, By End-User, 2020-2026 (USD Million)

8.4.9.4 Market Size, By Transplant Type, 2020-2026 (USD Million)

8.4.10 South Korea

8.4.10.1 Market Size, By Component, 2020-2026 (USD Million)

8.4.10.2 Market Size, By Application, 2020-2026 (USD Million)

8.4.10.3 Market Size, By End-User, 2020-2026 (USD Million)

8.4.10.4 Market Size, By Transplant Type, 2020-2026 (USD Million)

8.5 Latin America

8.5.1 Market Size, By Country 2020-2026 (USD Million)

8.5.2 Market Size, By Component, 2020-2026 (USD Million)

8.5.3 Market Size, By Application, 2020-2026 (USD Million)

8.5.4 Market Size, By End-User, 2020-2026 (USD Million)

8.5.5 Market Size, By Transplant Type, 2020-2026 (USD Million)

8.5.6 Brazil

8.5.6.1 Market Size, By Component, 2020-2026 (USD Million)

8.5.6.2 Market Size, By Application, 2020-2026 (USD Million)

8.5.6.3 Market Size, By End-User, 2020-2026 (USD Million)

8.5.6.4 Market Size, By Transplant Type, 2020-2026 (USD Million)

8.5.7 Mexico

8.5.7.1 Market Size, By Component, 2020-2026 (USD Million)

8.5.7.2 Market Size, By Application, 2020-2026 (USD Million)

8.5.7.3 Market Size, By End-User, 2020-2026 (USD Million)

8.5.7.4 Market Size, By Transplant Type, 2020-2026 (USD Million)

8.5.8 Argentina

8.5.8.1 Market Size, By Component, 2020-2026 (USD Million)

8.5.8.2 Market Size, By Application, 2020-2026 (USD Million)

8.5.8.3 Market Size, By End-User, 2020-2026 (USD Million)

8.5.8.4 Market Size, By Transplant Type, 2020-2026 (USD Million)

8.6 MEA

8.6.1 Market Size, By Country 2020-2026 (USD Million)

8.6.2 Market Size, By Component, 2020-2026 (USD Million)

8.6.3 Market Size, By Application, 2020-2026 (USD Million)

8.6.4 Market Size, By End-User, 2020-2026 (USD Million)

8.6.5 Market Size, By Transplant Type, 2020-2026 (USD Million)

8.6.6 Saudi Arabia

8.6.6.1 Market Size, By Component, 2020-2026 (USD Million)

8.6.6.2 Market Size, By Application, 2020-2026 (USD Million)

8.6.6.3 Market Size, By End-User, 2020-2026 (USD Million)

8.6.6.4 Market Size, By Transplant Type, 2020-2026 (USD Million)

8.6.7 UAE

8.6.7.1 Market Size, By Component, 2020-2026 (USD Million)

8.6.7.2 Market Size, By Application, 2020-2026 (USD Million)

8.6.7.3 Market Size, By End-User, 2020-2026 (USD Million)

8.6.7.4 Market Size, By Transplant Type, 2020-2026 (USD Million)

8.6.8 South Africa

8.6.8.1 Market Size, By Component, 2020-2026 (USD Million)

8.6.8.2 Market Size, By Application, 2020-2026 (USD Million)

8.6.8.3 Market Size, By End-User, 2020-2026 (USD Million)

8.6.8.4 Market Size, By Transplant Type, 2020-2026 (USD Million)

Chapter 9 Company Landscape

9.1 Competitive Analysis, 2020

9.2 Aithent Inc.

9.2.1 Company Overview

9.2.2 Financial Analysis

9.2.3 Strategic Positioning

9.2.4 Info Graphic Analysis

9.3 CareDx

9.3.1 Company Overview

9.3.2 Financial Analysis

9.3.3 Strategic Positioning

9.3.4 Info Graphic Analysis

9.4 Infor-Med Inc.

9.4.1 Company Overview

9.4.2 Financial Analysis

9.4.3 Strategic Positioning

9.4.4 Info Graphic Analysis

9.5 Transplant Connect

9.5.1 Company Overview

9.5.2 Financial Analysis

9.5.3 Strategic Positioning

9.5.4 Info Graphic Analysis

9.6 Talend

9.6.1 Company Overview

9.6.2 Financial Analysis

9.6.3 Strategic Positioning

9.6.4 Info Graphic Analysis

9.7 Inova

9.7.1 Company Overview

9.7.2 Financial Analysis

9.7.3 Strategic Positioning

9.7.4 Info Graphic Analysis

9.8 Afflo

9.8.1 Company Overview

9.8.2 Financial Analysis

9.8.3 Strategic Positioning

9.8.4 Info Graphic Analysis

9.9 TatvaSoft

9.9.1 Company Overview

9.9.2 Financial Analysis

9.9.3 Strategic Positioning

9.9.4 Info Graphic Analysis

9.10 Optum, Inc.

9.10.1 Company Overview

9.10.2 Financial Analysis

9.10.3 Strategic Positioning

9.10.4 Info Graphic Analysis

9.11 Other Companies

9.11.1 Company Overview

9.11.2 Financial Analysis

9.11.3 Strategic Positioning

9.11.4 Info Graphic Analysis

The Global Organ Transplantation Software and Services Market has been studied from the year 2019 till 2027. However, the CAGR provided in the report is from the year 2022 to 2027. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Organ Transplantation Software and Services Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe. Privacy

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

What is the projected market size of the global organ transplantation software and services market?

The global organ transplantation software and services market size is projected to grow at a CAGR value of 11.5% from 2022 and 2027.

Who are the major vendors in the organ transplantation software and services market?

Key and innovative vendors in the organ transplantation software and services market include Aithent Inc., CareDx, Infor-Med Inc., Transplant Connect, Talend, Inova, Afflo, TatvaSoft, Optum, Inc., LifeCell Corporation, Mid-America Transplant Services, Australian Red Cross Blood Service, Acelity L.P. Inc., CryoLife, Inc., Exactech Inc., Folio Biosciences, Dr. Franz Kohler Chemie GmbH, HealthSmart, DaVita, and Labcorp Transplant Services, among others.

Which region has the highest market share in the organ transplantation software and services market?

The North American region is estimated to hold the largest share of the organ transplantation software and services market.

What is the Covid-19 impact on future organ transplantation software and services manufacturers?

What are the major drivers in the organ transplantation software and services market?